- Home
- CTNT vs GTBP Comparison
CTNT vs GTBP Comparison
Compare CTNT & GTBP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CTNT
- GTBP
- Stock Information
- Founded
- CTNT 2016
- GTBP 1965
- Country
- CTNT United States
- GTBP United States
- Employees
- CTNT N/A
- GTBP N/A
- Industry
- CTNT
- GTBP Biotechnology: Pharmaceutical Preparations
- Sector
- CTNT
- GTBP Health Care
- Exchange
- CTNT Nasdaq
- GTBP Nasdaq
- Market Cap
- CTNT 6.5M
- GTBP 5.6M
- IPO Year
- CTNT 2023
- GTBP N/A
- Fundamental
- Price
- CTNT $1.37
- GTBP $2.30
- Analyst Decision
- CTNT Hold
- GTBP Strong Buy
- Analyst Count
- CTNT 1
- GTBP 1
- Target Price
- CTNT N/A
- GTBP $11.00
- AVG Volume (30 Days)
- CTNT 15.2K
- GTBP 36.1K
- Earning Date
- CTNT 05-12-2025
- GTBP 05-14-2025
- Dividend Yield
- CTNT N/A
- GTBP N/A
- EPS Growth
- CTNT N/A
- GTBP N/A
- EPS
- CTNT N/A
- GTBP N/A
- Revenue
- CTNT $455,805.00
- GTBP N/A
- Revenue This Year
- CTNT $258.05
- GTBP N/A
- Revenue Next Year
- CTNT N/A
- GTBP N/A
- P/E Ratio
- CTNT N/A
- GTBP N/A
- Revenue Growth
- CTNT N/A
- GTBP N/A
- 52 Week Low
- CTNT $1.25
- GTBP $1.72
- 52 Week High
- CTNT $236.16
- GTBP $10.66
- Technical
- Relative Strength Index (RSI)
- CTNT 27.79
- GTBP 46.49
- Support Level
- CTNT $1.25
- GTBP $2.12
- Resistance Level
- CTNT $1.93
- GTBP $2.45
- Average True Range (ATR)
- CTNT 0.13
- GTBP 0.17
- MACD
- CTNT -0.01
- GTBP -0.03
- Stochastic Oscillator
- CTNT 17.70
- GTBP 24.81
About CTNT Cheetah Net Supply Chain Service Inc.
Cheetah Net Supply Chain Service Inc is a supplier of parallel-import vehicles sourced in the U.S. to be sold in the China market. The parallel-import vehicles refer to those purchased by dealers directly from overseas markets and imported for sale through channels other than brand manufacturers' official distribution systems. The company purchases automobiles, luxury brands such as Mercedes, BMW, Porsche, Lexus, and Bentley, from the U.S. market and resells them to customers, including both U.S. and PRC parallel-import car dealers. The company derives profits from the price difference between buying and selling prices for parallel-import vehicles.
About GTBP GT Biopharma Inc.
GT Biopharma Inc is a clinical-stage biopharmaceutical company focused on the development and commercialization of novel immuno-oncology products in the United States. It is engaged in discovering, developing, and commercializing novel therapeutics from its proprietary product platform in a varied range of disease areas. The company mainly develops drugs focused on the treatment of cancer. Its TriKE (Tri-specific Killer Engager) platforms offer immuno-oncology products that can treat a range of hematologic malignancies, sarcoma, and solid tumors.